ACE and type 2 diabetes mellitus: Treatments for hypertension and type 2 diabetes, including Angiotensin Converting Enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), reduce urinary potassium excretion, which can lead to hyperkalaemia [295,296].